Zhang Qing
Papers
1
Total Citations
96
H-Index
1
About
Dr. Zhang Qing is a leading figure in oncologic imaging, with a focused expertise in the preoperative staging of prostate cancer. Her seminal work, "Comparison of 68Ga-PSMA-11 PET-CT with mpMRI for preoperative lymph node staging in patients with intermediate to high-risk prostate cancer" (2017, 96 citations), has been highly influential in redefining clinical protocols. In this landmark study, Dr. Zhang directly compared the diagnostic accuracy of 68Ga-PSMA-11 PET-CT against multiparametric MRI (mpMRI) for detecting lymph node metastases in patients undergoing radical prostatectomy. Her findings demonstrated the superior sensitivity and specificity of PSMA PET-CT, establishing it as a critical tool for guiding surgical planning and reducing unnecessary pelvic lymph node dissections. This contribution has not only advanced precision medicine in urologic oncology but also shaped international guidelines for high-risk prostate cancer management. Dr. Zhang’s work continues to inspire further research into hybrid imaging techniques, cementing her reputation as a pioneer in translating molecular imaging into tangible clinical benefits.
Research Focus
Key Achievements
Top Papers
- 1